Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/11817| Title: | Levetiracetam-Induced Seizure Aggravation in Patients With Focal Cortical Dysplasia | Authors: | Cvetkovska, Emilija Kuzmanovski, I Babunovska, Marija Boshkovski, Bojan Aleksovska, Katina Trencevska Kiteva, Gordana |
Issue Date: | 2018 | Publisher: | Lippincott, Williams & Wilkins | Journal: | Clinical Neuropharmacology | Abstract: | The choice of antiepileptic drug is typically based on seizure type, and there is no evidence for superior effectiveness or potential deterioration of particular antiepileptic drug in specific etiologic subgroups. The aim of the study was to identify etiological factor(s) associated with increased risk of seizure aggravation with levetiracetam (LEV). | URI: | http://hdl.handle.net/20.500.12188/11817 | DOI: | 10.1097/WNF.0000000000000304 |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.